Search This Blog

Thursday, April 7, 2022

Bristol-Myers resumed at Underweight by Morgan Stanley

 Target $64

https://finviz.com/quote.ashx?t=BMY&ty=c&ta=1&p=d


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.